ArticleCureus2025
Can the Complexity of Diagnosing Pulmonary Embolism in Patients With Obesity and Multiple Comorbidities Provide an Explanation of the Obesity Paradox?
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This report describes three cases of patients with obesity who had chronic comorbidities and presented with documented causes of dyspnea before hospital admission. The challenges in recognising and diagnosing pulmonary embolism (PE) in these patients are highlighted and discussed in light of current literature. It is possible that delayed or missed diagnoses are common among patients with a history of dyspnea, a symptom frequently observed in individuals with obesity. A hypothesis is proposed based on existing medical literature to explain the so-called "obesity paradox." This hypothesis suggests that the seemingly lower relative risk of mortality from PE in patients with obesity, compared to their counterparts without obesity, may stem from a higher rate of missed diagnoses in the former who have multiple comorbidities, many of which often present with dyspnea, besides other symptoms. Such a situation could lead to misleading data indicating better outcomes due to selection bias, where healthier patients with obesity but without comorbid conditions are more easily identified and receive prompt treatment. In contrast, delays or missed diagnoses in more vulnerable patients with obesity who have multiple health issues may result in significantly worse outcomes, potentially explaining the increased all-cause mortality associated with obesity. While this paper specifically examines PE, the same principle may apply to other medical emergencies involving patients with obesity who present with acute dyspnea. Specific studies are needed to simultaneously assess the outcomes for both diagnosed and undiagnosed patients with obesity to prove or disprove this hypothesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.